1887
Rapid communication Open Access
Like 0

Abstract

HIV testing was offered to 2,185 people receiving mpox (formerly monkeypox) vaccination, who reported not being HIV positive. Among them 390 were current PrEP users, and 131 had taken PrEP in the past. Of 958 individuals consenting testing, six were newly diagnosed with HIV. Two patients had symptomatic primary HIV infection. None of the six patients had ever taken PrEP. Mpox vaccination represents an important opportunity for HIV testing and counselling about risk reduction and PrEP.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2022.27.48.2200890
2022-12-01
2023-02-02
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2022.27.48.2200890
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/27/48/eurosurv-27-48-1.html?itemId=/content/10.2807/1560-7917.ES.2022.27.48.2200890&mimeType=html&fmt=ahah

References

  1. World Health Organization (WHO). Multi-country monkeypox outbreak in non-endemic countries, 2022. Geneva: WHO; 2022. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON385
  2. World Health Organization (WHO). WHO Director-General declares the ongoing monkeypox outbreak a Public Health Emergency of International Concern. Geneva: WHO; 2022. Available from: https://www.who.int/europe/news/item/23-07-2022-who-director-general-declares-the-ongoing-monkeypox-outbreak-a-public-health-event-of-international-concern
  3. World Health Organization (WHO). Vaccines and immunization for monkeypox: Interim guidance, 24 August 2022. Geneva: WHO;2022. Available from: https://www.who.int/publications/i/item/WHO-MPOX-Immunization-2022.2-eng
  4. Vaughan AM, Cenciarelli O, Colombe S, Alves de Sousa L, Fischer N, Gossner CM, et al. A large multi-country outbreak of monkeypox across 41 countries in the WHO European Region, 7 March to 23 August 2022. Euro Surveill. 2022;27(36):2200620.  https://doi.org/10.2807/1560-7917.ES.2022.27.36.2200620  PMID: 36082686 
  5. Gessain A, Nakoune E, Yazdanpanah Y. Monkeypox. N Engl J Med. 2022;387(19):1783-93.  https://doi.org/10.1056/NEJMra2208860  PMID: 36286263 
  6. Mussini C, Guaraldi G, Orkin C. Monkeypox vaccination-an opportunity for HIV prevention. Lancet HIV. 2022;9(11):e741-2.  https://doi.org/10.1016/S2352-3018(22)00292-2 
  7. Ministero della Salute. 05/08/2022 CIRCOLARE del Ministero della Salute n. 35365. Indicazioni ad interim sulla strategia vaccinale contro il vaiolo delle scimmie (MPOX). [Circular of the Ministry of Health n. 35365. Interim indications on the vaccination strategy against monkeypox (MPOX)]. Italian. Rome: Ministero della Salute; 2022. Available from: https://www.salute.gov.it/portale/malattieInfettive/archivioNormativaMalattieInfettive.jsp
  8. European Clinical AIDS Society. EACS GUIDELINES. Version 11.1 October 2022. Brussels: European Clinical AIDS Society; 2022.
  9. UNAIDS. HIV PREVENTION 2025 – ROAD MAP: Getting on track to end AIDS as a public health threat by 2030. Geneva: Joint United Nations Programme on HIV/AIDS; 2022. Licence: CC BY-NC-SA 3.0 IGO.
  10. UNAIDS. Understanding fast track accelerating action to end AIDS epidemic by 2030. Geneva: Joint United Nations Programme on HIV/AIDS; [Acessed 30 Nov 2022]. Available from: https://www.unaids.org/en/resources/documents/2014/JC2686_WAD2014report#:~:text=The%20world%20is%20embarking%20on,no%20one%20is%20left%20behind
  11. Griffin S. HIV: Two in three people have trouble getting PrEP, finds survey. BMJ. 2022;379:o2667.  https://doi.org/10.1136/bmj.o2667  PMID: 36332912 
  12. Not PrEPared: barriers to accessing HIV prevention drugs in England. London: National AIDS trust; Oct 2022. Available from: https://www.nat.org.uk/sites/default/files/publications/Not%20PrEPared.pdf
  13. Talari K, Goyal M. Retrospective studies - utility and caveats. J R Coll Physicians Edinb. 2020;50(4):398-402.  https://doi.org/10.4997/jrcpe.2020.409  PMID: 33469615 
/content/10.2807/1560-7917.ES.2022.27.48.2200890
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error